Work

Cryptophycins-309, 249 and other cryptophycin analogs: Preclinical efficacy studies with mouse and human tumors

Year: 2005

Type: article

Source: Investigational New Drugs

DOI: 10.1007/s10637-005-6729-9

Authors: Jian Liang, Richard E. Moore, Eric D. Moher, John E. Munroe, Rima S. Al-awar, David A. Hay, David L. Varie, Tony Y. Zhang, James A. Aikins, Michael J. Martinelli, Chuan Shih, James E. Ray, Lowell L. Gibson, Vasu Vasudevan, Lisa Polin, Kathryn White, Juiwanna Kushner, Chiab Simpson, Susan Pugh, Thomas H. Corbett

Institutions: University of Hawaiʻi at Mānoa, Eli Lilly (United States), Wayne State University, The Barbara Ann Karmanos Cancer Institute

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Barbara Ann Karmanos Cancer Institute, National Institutes of Health, National Cancer Institute

Awards: G1785762820, G497553939, ANTITUMOR AGENTS FROM BLUE-GREEN ALGAE

OpenAlex ID: W2001301872

FWCI: 1.516

Cites: 30

Cited by: 75

Related to: 10